LBA74 Pembrolizumab plus chemotherapy vs chemotherapy as neoadjuvant and adjuvant therapy in locally-advanced gastric and gastroesophageal junction cancer: The phase III KEYNOTE-585 study
Kohei Shitara, Sun Young Rha, Lucjan Wyrwicz, Takashi Oshima, Nina Karaseva, M. A. Osipov, Hisateru Yasui, Hiroshi Yabusaki, S. G. Afanasyev, Park Yk, S-E. Al-Batran, Takaki Yoshikawa, P.E. Yanez Weber, Maria Di Bartolomeo, Sara Lonardi, Xuemin Fang, C-S. Shih, Pooja Bhagia, Y-J. Bang
Topics & Concepts
MedicinePembrolizumabChemotherapyGastroesophageal JunctionCancerOncologyInternal medicineAdjuvantAdjuvant chemotherapyPhases of clinical researchAdenocarcinomaImmunotherapyBreast cancerGastric Cancer Management and OutcomesCancer Immunotherapy and BiomarkersGastrointestinal Tumor Research and Treatment